Guardant Health (GH) Capital Expenditures (2017 - 2026)

Guardant Health has reported Capital Expenditures for 10 years, with the latest figure at $11.8 million in Q2 2026.

• Quarterly Capital Expenditures rose 108.16% year-over-year to $11.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $55.5 million (up 67.37% YoY) and the FY2025 annual result came in at $48.3 million, up 37.68% from the prior year.
• Capital Expenditures advanced to $11.8 million in Q2 2026 per GH's latest filing, from $5.6 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $27.8 million in Q4 2025 and troughed at $2.4 million in Q3 2023.
• A 5-year average of $11.0 million and a median of $7.5 million in 2023 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2023 and 2024: Capital Expenditures plunged 89.08% in 2023, then surged 362.96% in 2024.
• Over 5 years, Capital Expenditures stood at $10.0 million in 2022, then plunged by 59.23% to $4.1 million in 2023, then soared by 362.96% to $18.9 million in 2024, then jumped by 47.54% to $27.8 million in 2025, then sank by 57.77% to $11.8 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $11.8 million, $5.6 million, and $27.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.